169 related articles for article (PubMed ID: 15879028)
1. Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland.
Paldanius M; Bloigu A; Alho M; Leinonen M; Saikku P
Clin Diagn Lab Immunol; 2005 May; 12(5):654-9. PubMed ID: 15879028
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in pneumonia patients in four major hospitals in Trinidad.
Nagalingam NA; Adesiyun AA; Swanston WH; Bartholomew M
New Microbiol; 2004 Oct; 27(4):345-51. PubMed ID: 15646048
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of Chlamydophila pneumoniae seropositivity and risk factors in patients with atherosclerotic vascular disease in Sivas, Turkey].
Kılıç ZB; Poyraz O; Kılıç AT
Mikrobiyol Bul; 2012 Jan; 46(1):156-8. PubMed ID: 22399186
[TBL] [Abstract][Full Text] [Related]
4. Serological study on Chlamydophila pneumoniae in patients with community-acquired pneumonia.
Ciarrocchi G; De Benedetto F; Fogliani V; Magliano E; Del Prete R; Miragliotta G
New Microbiol; 2004 Oct; 27(4):335-43. PubMed ID: 15646047
[TBL] [Abstract][Full Text] [Related]
5. Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit.
Paldanius M; Bloigu A; Leinonen M; Saikku P
Clin Diagn Lab Immunol; 2003 Jan; 10(1):8-12. PubMed ID: 12522032
[TBL] [Abstract][Full Text] [Related]
6. Chlamydophila pneumoniae diagnostics: importance of methodology in relation to timing of sampling.
Hvidsten D; Halvorsen DS; Berdal BP; Gutteberg TJ
Clin Microbiol Infect; 2009 Jan; 15(1):42-9. PubMed ID: 19046171
[TBL] [Abstract][Full Text] [Related]
7. Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G, and A antibodies.
Bennedsen M; Berthelsen L; Lind I;
Clin Diagn Lab Immunol; 2002 Jul; 9(4):833-9. PubMed ID: 12093682
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of Chlamydia pneumoniae antibodies in children between 7 months and 8 years of age.
Volanen I; Vainionpää R; Ilonen J; Markula P; Kallio K; Kaitosaari T; Helenius H; Simell O
Scand J Infect Dis; 2003; 35(8):471-7. PubMed ID: 14514146
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia.
Wellinghausen N; Straube E; Freidank H; von Baum H; Marre R; Essig A
Int J Med Microbiol; 2006 Nov; 296(7):485-91. PubMed ID: 16890487
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia pneumoniae antibody levels before coronary events in the Helsinki Heart Study as measured by different methods.
Paldanius M; Leinonen M; Virkkunen H; Tenkanen L; Sävykoski T; Mänttäri M; Saikku P
Diagn Microbiol Infect Dis; 2006 Nov; 56(3):233-9. PubMed ID: 16757141
[TBL] [Abstract][Full Text] [Related]
11. Comparison of a new commercial EIA kit and the microimmunofluorescence technique for the determination of IgG and IgA antibodies to Chlamydia pneumoniae.
Gnarpe J; Nääs J; Lundbäck A
APMIS; 2000 Dec; 108(12):819-24. PubMed ID: 11252815
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serological tests for detection of immunoglobulin M antibodies to Chlamydophila pneumoniae.
Miyashita N; Ouchi K; Kawasaki K; Komura H; Kawai Y; Tsumura N; Bannai H; Iwata S; Oka M
Respirology; 2008 May; 13(3):427-31. PubMed ID: 18399867
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of enzyme linked immunosorbent assays species specific in the detection of Chlamydia trachomatis and Chlamydophila pneumoniae IgG antibodies in patients with genital infections or respiratory tract infections.
Frikha-Gargouri O; Znazen A; Gdoura R; Gargouri B; Arab NB; Jemaa MB; Hammami A
Pathol Biol (Paris); 2008 May; 56(3):143-7. PubMed ID: 18178034
[TBL] [Abstract][Full Text] [Related]
14. [Anti-C. pneumoniae IgG, IgA and IgM antibodies in patients undergoing coronary artery bypass grafting].
Dyszkiewicz W; Paul M; Chylak J; Jemielity M
Pol Merkur Lekarski; 2002 Jan; 12(67):11-4. PubMed ID: 11957794
[TBL] [Abstract][Full Text] [Related]
15. A new microimmunofluorescence test for the detection of Chlamydia pneumoniae specific antibodies.
Fernández F; Gutiérrez J; Mendoza J; Linares J; Soto MJ
J Basic Microbiol; 2004; 44(4):275-9. PubMed ID: 15266599
[TBL] [Abstract][Full Text] [Related]
16. [Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma].
Azzouzi N; Elhataoui M; Bakhatar A; Takourt B; Benslimane A
Ann Biol Clin (Paris); 2005; 63(2):179-84. PubMed ID: 15771975
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of chlamydia pneumoniae antibodies in patients with coronary heart disease].
Podsiadły E; Kruk M; Przyłuski J; Deptuch T; Ruzyłło W; Tylewska-Wierzbanowska S
Przegl Epidemiol; 2001; 55(3):253-60. PubMed ID: 11761832
[TBL] [Abstract][Full Text] [Related]
18. Chlamydia pneumoniae IgA- and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay.
Halvorsen DS; Børvik T; Njølstad I; Gutteberg TJ; Vorland LH; Hansen JB
J Intern Med; 2002 Feb; 251(2):142-7. PubMed ID: 11905590
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serological tests detecting Chlamydophila pneumoniae-specific immunoglobulin M antibody.
Miyashita N; Obase Y; Fukuda M; Shoji H; Mouri K; Yagi S; Yoshida K; Ouchi K; Oka M
Intern Med; 2006; 45(20):1127-31. PubMed ID: 17106155
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and optimization of ELISA for detection of anti-Chlamydophila pneumoniae IgG and IgA in patients with coronary heart diseases.
Ciervo A; Petrucca A; Visca P; Cassone A
J Microbiol Methods; 2004 Oct; 59(1):135-40. PubMed ID: 15325761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
